FT
FireCyte Therapeutics
FireCyte is a neuroscience-based ophthalmology company developing novel multi-target intravitreal injected proteins for retinal disorders. These fusion proteins engage SORT1 and DCC to modulate microglial behavior, offering both anti-inflammatory and neuroprotective effects. The company's approach focuses on direct protection of neurons through targeted neuroscience research.
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- FireCyte is a neuroscience-based ophthalmology company developing novel multi-target intravitreal injected proteins for retinal disorders. These fusion proteins engage SORT1 and DCC to modulate microglial behavior, offering both anti-inflammatory and neuroprotective effects. The company's approach focuses on direct protection of neurons through targeted neuroscience research.